Healthcare
Live Price
Offline$6.74
+0.75% today
1Y Change
-27.02%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Senseonics Holdings, Inc. (SENS) is a Healthcare stock with a market cap of $210.00M and listed on NASDAQ. The stock last traded around $6.74 and down 27.0% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +56.9%, EPS growth of +33.6%, a dividend yield of 0.0%. What stands out right now is revenue +56.9%, EPS +33.6%, free cash flow +3.9% with operating margin -184.9% and ROIC -66.6%. Valuation sits in the middle of the pack at price/sales 5.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SENS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SENS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SENS Max Drawdown
-57.19%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SENS and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$13.7M
-16.6% YoY
FY Net Income
-$302.5M
-312.8% YoY
Free Cash Flow
-$56.3M
+15.5% YoY
Revenue Growth
+56.9%
EPS Growth
+33.6%
Gross Margin
45.0%
Net Margin
-189.9%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 35M | 22M | 22M | 16M | 14M |
| Gross Profit | 16M | 533K | 3M | 3M | -811K |
| Operating Income | -68M | -75M | -76M | -69M | -57M |
| EBITDA | -64M | -69M | -48M | 162M | -285M |
| Net Income | -69M | -79M | -60M | 142M | -302M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 41M | 75M | 76M | 36M | 33M |
| Total Assets | 126M | 100M | 138M | 178M | 199M |
| Total Liabilities | 65M | 117M | 102M | 180M | 384M |
| Shareholder Equity | 61M | -17M | 36M | -3M | -186M |
| Total Debt | 41M | 61M | 48M | 75M | 64M |
| Net Debt | 822K | -14M | -28M | 40M | 31M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
56M
+15.4% YoY
Capital Expenditures
210K
+32.7% YoY
Free Cash Flow
56M
+15.5% YoY
Key ratios
Gross Margin
45.0%
Operating Margin
-184.9%
Net Margin
-189.9%
ROE
-104.2%
Debt / Equity
0.68x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.